Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 537,198	$ 166,911
Accounts receivable	1,850,375
Other current assets	17,180	2,343
Total current assets	2,404,753	169,254
Patents, net of accumulated amortization of $1,617,762 and $1,088,280, respectively	2,754,354	2,045,618
Total assets	5,159,107	2,214,872
Current liabilities
Accounts payable and accrued liabilities	3,362,932	338,748
Loans payable - third party	147,000	163,000
Purchase price of patents, current portion	569,386	100,000
Loan payable - related party, net of unamortized discount and debt issuance costs of $189,705 and $379,948, respectively	4,483,105	4,292,862
Accrued interest - loans payable related party	117,780	117,780
Accrued interest - loans payable third party	270,185	281,514
Derivative liability	595,000	540,000
Total current liabilities	9,545,388	5,833,904
Non-current liabilities
Contingent funding liabilities	20,378	150,000
Purchase price of patents, net of unamortized discount of $282,503 and $105,172, respectively	1,442,497	769,829
Total liabilities	11,008,263	6,753,733
Stockholders' deficit
Preferred stock, par value $0.00003 per share - authorized 10,000,000 shares - no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 10,000,000,000 at December 31, 2019 and 2018; shares issued and outstanding 383,038,334 at December 31, 2019 and 2018	11,491	11,491
Additional paid-in capital	14,107,782	14,107,782
Accumulated deficit	(19,968,668)	(18,659,892)
Total Quest Patent Research Corporation deficit	(5,849,395)	(4,540,619)
Non-controlling interest in subsidiary	239	1,758
Total stockholders' deficit	(5,849,156)	(4,538,861)
Total liabilities and stockholders' deficit	$ 5,159,107	$ 2,214,872